| Last update: 05.12.2025 14:20:56 |
Parallel Symposium Roche | ||||
| 10:14 - 10:14 | Parallel Symposium Roche No Speaker assigned to this Slot. | |||
| 10:15 - 11:00 | Unlocking Better Outcomes: Advances in Immunotherapy for Lupus Nephritis Andrea Rubbert-Roth, St.Gallen / Harald Seeger, Baden | 04.12.25 14:11 | ||
Parallel Symposium Novartis | ||||
| 11:29 - 11:29 | Parallel Symposium Novartis No Speaker assigned to this Slot. | |||
| 11:30 - 12:15 | A new Era for managing IgAN + C3G Uyen Huynh-Do, Bern / Patricia Hirt-Minkowski, Basel | 04.12.25 14:47 | ||
Parallel Symposium Swedish Orphan Biovitrum AG | ||||
| 12:14 - 12:14 | Parallel Symposium Swedish Orphan Biovitrum AG No Speaker assigned to this Slot. | |||
| 12:15 - 12:20 | Chair's Welcome Uyen Huynh-Do, Bern | |||
| 12:15 - 13:00 | The Future of C3G and IC-MPGN Treatment:
Innovations and Implications for Adults and Adolescents Herr Dominik Olszewski, Unterägeri / Welcome to Interlaken, | 04.12.25 08:33 | ||
| 12:20 - 12:30 | Glomerulopathies: Pathological Mechanism, Diagnosis, Unmet Need, Treatment Options
- Patient case presentation Fadi Fakhouri, Lausanne | |||
| 12:30 - 12:40 | Understanding C3G and IC-MPGN Disease Progression in Pediatric and Adolescent Populations - Patient case presentation Wesley Hayes, Zürich | |||
| 12:40 - 12:50 | Transition: Implications for a successful transition process of patients with renal impairment Uyen Huynh-Do, Bern | |||
| 12:50 - 13:00 | Closing Remars and Q&A Uyen Huynh-Do, Bern | |||
Parallel Symposium Spirig HealthCare AG | ||||
| 14:00 - 14:03 | Welcome and Opening Remarks Olivier Phan, Lausanne | |||
| 14:00 - 14:45 | Unlocking the Potential: IgAN-Care with Nefecon*-A New Era in Treatment. Guidelines, Evidence, and the Swiss Framework
*Budesonid targeted release Harald Seeger, Baden | 04.12.25 10:15 | ||
| 14:03 - 14:23 | KDIGO 2025 IgA Nephropathy Guidelines: Key Updates and Clinical Implications Jürgen Floege, Aachen | |||
| 14:23 - 14:38 | Nefecon (Kinpeygo®) in IgA Nephropathy: Evidence and the Swiss Framework Harald Seeger, Baden | |||
| 14:38 - 14:45 | Q&A and Concluding Remarks Olivier Phan, Lausanne | |||